Autonomix Medical (AMIX) Director Lori Bisson Receives 13,000-Share Award

What Happened Lori Bisson, a director of Autonomix Medical, received a restricted stock award of 13,000 shares reported on Form 4 for the transaction dated September 3, 2026. The filing lists the acquisition as an award (code A); no per-share price or total dollar value is provided (N/A). This is an award/grant (an acquisition), not an open-market purchase or sale.

Key Details

• Transaction date reported: 2026-09-03; Form 4 filed: 2026-09-08 (filed within the required reporting window).
• Price/Value: Listed as N/A in the filing (restricted stock award rather than a cash purchase).
• Shares acquired: 13,000 restricted shares.
• Shares owned after transaction: Not stated in the filing.
• Footnote: F1 — These restricted shares vest one year from the issuance date (i.e., vesting on 2027-09-03).
• No 10b5-1, tax-withholding, or sale codes were indicated in this report.

Context Restricted stock awards to directors are common compensation and typically vest over time; they represent future ownership if vesting conditions are met and do not indicate an immediate market sale or purchase intent. This report documents the grant/award itself — because the shares vest later, any market impact would depend on future vesting and any subsequent sales.